Skip to content

Price / book at other companies

Quest Diagnostics logo
Quest DiagnosticsDGX
2.9×+0.2×
NeoGenomics logo
NeoGenomicsNEO
1.2×-0.2×
Illumina logo
IlluminaILMN
+1.7×
Veracyte logo
VeracyteVCYT
1.9×0.0×
Guardant Health logo
Guardant HealthGH
36.8×
Natera, Inc. logo
Natera, Inc.NTRA
16×+0.6×

Other financials

Income statement

See full
Revenue$15.5M-24.9%
Gross profit$281.0K-96.1%
Operating income-$32.2M-81.7%
Net income-$30.0M-90.7%
EPS (diluted)-$0.29-61.1%

Balance sheet

See full
Cash & equivalents$73.6M+3.7%
Total debt$39.0M-6.2%
Total equity$254.8M+22.9%
Total assets$325.4M+19.1%

Cash flow

See full
Operating cash flow-$22.5M-25.1%
CapEx$3.2M+27.1%
Free cash flow-$25.7M-25.4%

Valuation

See full
Market cap$1.19B+110%
Enterprise value$1.16B+115%
P/S18.4×+11.8×

Profitability

See full
Gross margin13.7%-19.6pp
Operating margin-158.9%-5,457pp
Net margin-148.1%+154pp
FCF margin-131.2%-453pp

Returns & leverage

See full
Return on equity-41.4%-6.7pp
Debt / equity0.2×0.0×
Current ratio6.6×-0.3×

Where this comes from

Calculated from Personalis, Inc.’s reported figures.

Based on the most recent quarter.

The official record: Personalis, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Personalis, Inc.'s price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Personalis, Inc.'s price / book?
Personalis, Inc. (PSNL) reported price / book of 2.6× in Q1 2026.
How has Personalis, Inc.'s price / book changed year-over-year?
Personalis, Inc.'s price / book increased by 75.1% year-over-year, from 1.5× to 2.6×.
What is the long-term trend for Personalis, Inc.'s price / book?
Over 5 years (2020 to 2025), Personalis, Inc.'s price / book has grown at a -20.3% compound annual growth rate (CAGR), from 8.4× to 2.7×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.